Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes

Journal of Leukocyte Biology

Volumn 81, Issue 2, 2007, Pages 520-527

  Ding, Yong ^a   Kantarci, Alpdogan ^a   Hasturk, Hatice ^a   Trackman, Philip C ^a,b   Malabanan, Alan ^b   Van Dyke, Thomas E ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced glycation end products; Hyperglycemia; Monocytes macrophages; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PROTEIN S100B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; ZYMOSAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; GLYCATION; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPEROSMOLARITY; MALE; MONOCYTE; MONONUCLEAR PHAGOCYTE; OSMOTIC PRESSURE; PRIORITY JOURNAL; RESPIRATORY BURST;

ADULT; ANTIGENS, NEOPLASM; DIABETES MELLITUS; FEMALE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NERVE GROWTH FACTORS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; ZYMOSAN;

EID: 33846701659     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0406262     Document Type: Article

References (38)

1. Delamaire, M., Maugendre, D., Moreno, M., Le Goff, M. C., Allannic, H., Genetet, B. (1997) Impaired leucocyte functions in diabetic patients. Diabet. Med. 14, 29-34.
2. Mohsenin, V., Latifpour, J. (1990) Respiratory burst in alveolar macrophages of diabetic rats. J. Appl. Physiol. 68, 2384-2390.
3. Kitahara, M., Eyre, H. J., Lynch, R. E., Rallison, M. L., Hill, H. R. (1980) Metabolic activity of diabetic monocytes. Diabetes 29, 251-256.
4. Hill, H. R., Hogan, N. A., Rallison, M. L., Santos, J. I., Charette, R. P., Kitahara, M. (1982) Functional and metabolic abnormalities of diabetic monocytes. Adv. Exp. Med. Biol. 141, 621-628.
5. Chang, F. Y., Shaio, M. F. (1995) Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 29, 121-127.
6. Vlassara, H. (2001) The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab. Res. Rev. 17, 436-443.
7. Brownlee, M., Cerami, A., Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321.
8. Kirstein, M., Brett, J., Radoff, S., Ogawa, S., Stern, D., Vlassara, H. (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA 87, 9010-9014.
9. Khechai, F., Ollivier, V., Bridey, F., Amar, M., Hakim, J., de Prost, D. (1997) Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler. Thromb. Vasc. Biol. 17, 2885-2890.
10. Heidland, A., Sebekova, K., Schinzel, R. (2001) Advanced glycation end products and the progressive course of renal disease. Am. J. Kidney Dis. 38 (Suppl. 1), S100-S106.
11. Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901.
12. Zimmer, D. B., Chessher, J., Wilson, G. L., Zimmer, W. E. (1997) S100A1 and S100B expression and target proteins in type I diabetes. Endocrinology 138, 5176-5183.
13. Kosaki, A., Hasegawa, T., Kimura, T., Iida, K., Hitomi, J., Matsubara, H., Mori, Y., Okigaki, M., Toyoda, N., Masaki, H., Inoue-Shibata, M., Nishikawa, M., Iwasaka, T. (2004) Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 89, 5423-5428.
14. Suzuki, F., Kato, K. (1985) Inhibition of adipose S-100 protein release by insulin. Biochim. Biophys. Acta 845, 311-316.
15. Halliwell, B., Gutteridge, J. M. C. (1999) Free Radicals in Biology and Medicine, 3rd ed., Oxford, UK, Oxford Science, 33-34.
16. Babior, B. M. (1984) The respiratory burst of phagocytes. J. Clin. Invest. 73, 599-601.
17. (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28, 1039-1057.
18. Clark Jr., M. J., Sterrett, J. J., Carson, D. S. (2000) Diabetes guidelines: a summary and comparison of the recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists. Clin. Ther. 22, 899-910.
19. Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., Schmidt, A. M. (1999) N(ε)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274, 31740-31749.
20. Chanock, S. J., el Benna, J., Smith, R. M., Babior, B. M. (1994) The respiratory burst oxidase. J. Biol. Chem. 269, 24519-24522.
21. Sagone Jr., A. L., Mendelson, D. S., Metz, E. N. (1977) The effect of sodium azide on the chemiluminescence of granulocytes - evidence for the generation of multiple oxygen radicals. J. Lab. Clin. Med. 89, 1333-1340.
22. McPhail, L. C., Snyderman, R. (1983) Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. J. Clin. Invest. 72, 192-200.
23. Li, Q., Cathcart, M. K. (1997) Selective inhibition of cytosolic phospholipase A2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation. J. Biol. Chem. 272, 2404-2411.
24. Vey, E., Zhang, J. H., Dayer, J. M. (1992) IFN-γ and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J. Immunol. 149, 2040-2046.
25. Sumi, D., Hayashi, T., Matsui-Hirai, H., Jacobs, A. T., Ignarro, L. J., Iguchi, A. (2003) 17β-Estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells. Biochim. Biophys. Acta 1640, 113-118.
26. Delbosc, S., Morena, M., Djouad, F., Ledoucen, C., Descomps, B., Cristol, J. P. (2002) Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J. Cardiovasc. Pharmacol. 40, 611-617.
27. Martindale, J. L., Holbrook, N. J. (2002) Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15.
28. Devaraj, S., Jialal, I. (2000) Low-density lipoprotein postsecretory modi-fication, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of α-tocopherol supplementation. Circulation 102, 191-196.
29. Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C., De Cesare, D., De Blasis, G., Muraro, R., Bei, R., Chiarelli, F., Schmidt, A. M., Cuccurullo, F., Mezzetti, A. (2003) The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108, 1070-1077.
30. Lopes-Virella, M. F., Virella, G. (1992) Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41 (Suppl. 2), 86-91.
31. Salvi, G. E., Collins, J. G., Yalda, B., Arnold, R. R., Lang, N. P., Offenbacher, S. (1997) Monocytic TNF α secretion patterns in IDDM patients with periodontal diseases. J. Clin. Periodontol. 24, 8-16.
32. Hou, F. F., Reddan, D. N., Seng, W. K., Owen Jr., W. F. (2001) Pathogenesis of β(2)-microglobulin amyloidosis: role of monocytes/macrophages. Semin. Dial. 14, 135-139.
33. Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., Kondo, M. (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int. 40, 1007-1012.
34. Goova, M. T., Li, J., Kislinger, T., Qu, W., Lu, Y., Bucciarelli, L. G., Nowygrod, S., Wolf, B. M., Caliste, X., Yan, S. F., Stern, D. M., Schmidt, A. M. (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am. J. Pathol. 159, 513-525.
35. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I., Brownlee, M. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790.
36. Jacob, S. S., Shastry, P., Sudhakaran, P. R. (2001) Influence of non-enzymatically glycated collagen on monocyte-macrophage differentiation. Atherosclerosis 159, 333-341.
37. Meldrum, D. R., Cleveland Jr., J. C., Moore, E. E., Partrick, D. A., Banerjee, A., Harken, A. H. (1997) Adaptive and maladaptive mechanisms of cellular priming. Ann. Surg. 226, 587-598.
38. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26, 171-176.